The role of non-coding RNAs in haemoglobin regulation

Date

2009

Supervisor/s

Journal Title

Journal ISSN

Volume Title

Publisher

Cranfield University

Department

Type

Thesis or dissertation

ISSN

Format

Free to read from

Citation

Abstract

Non-coding RNAs appear to play a role in gene regulation by modulating chromatin structure. There is mounting evidence suggesting an essential role for non-coding RNAs in the complex process of the genetic regulation of the β-globin locus. Preliminary observations indicate that the BGL3 non-coding transcript may be involved in an RNA-protein interaction and may be interacting with chromatin in the β-globin locus as part of a regulatory function within the locus. However, the expression profile of this non-coding transcript has not yet been characterized and nothing is known about its mode of action. Here it is shown that the BGL3 transcript is dynamically up-regulated upon haemin induction of the K562 cell line (a human erythroleukemic cell line). To determine whether there is a correlation between the BGL3 transcript expression and the expression of the γ- and β-globin genes, the levels of the BGL3 transcript in K562 cells were perturbed by knocking it down using the RNA interference pathway. The effect of the knockdown of the BGL3 transcript was tested on the expression levels of the γ- and β-globin genes, which were quantified using qRT-PCR. Our results are the first, to our knowledge, that describe a developmentally regulated expression of the BGL3 non-coding transcript in haemin-induced K562 cells, and provide evidence that suggests that this transcript may be involved in the silencing of the β-globin gene.

Description

Software Description

Software Language

Github

Keywords

BGL3 transcript, human β-globin locus, intergenic transcription, K562 cells, globin switching

DOI

Rights

© Cranfield University, 2009. All rights reserved. No part of this publication may be reproduced without the written permission of the copyright holder.

Relationships

Relationships

Supplements

Funder/s